APA (7th ed.) Citation

XR, L., POK, C., GH, L., YL, L., JWP, L., HN, O., . . . HS, H. (2022). Montreal cognitive assessment as a screening instrument for cognitive impairment in systemic lupus erythematosus patients without overt neuropsychiatric manifestations. Lupus, 31(14), 1759. https://doi.org/10.1177/09612033221132237

Chicago Style (17th ed.) Citation

XR, Lim, et al. "Montreal Cognitive Assessment as a Screening Instrument for Cognitive Impairment in Systemic Lupus Erythematosus Patients Without Overt Neuropsychiatric Manifestations." Lupus 31, no. 14 (2022): 1759. https://doi.org/10.1177/09612033221132237.

MLA (9th ed.) Citation

XR, Lim, et al. "Montreal Cognitive Assessment as a Screening Instrument for Cognitive Impairment in Systemic Lupus Erythematosus Patients Without Overt Neuropsychiatric Manifestations." Lupus, vol. 31, no. 14, 2022, p. 1759, https://doi.org/10.1177/09612033221132237.